| The MDM2-p53 pathway revisited S Nag, J Qin, KS Srivenugopal, M Wang, R Zhang Journal of biomedical research 27 (4), 254, 2013 | 431 | 2013 |
| Ginsenosides as Anticancer Agents: In vitro and in vivo Activities, Structure–Activity Relationships, and Molecular Mechanisms of Action SA Nag, JJ Qin, W Wang, MH Wang, H Wang, R Zhang Frontiers in pharmacology 3, 25, 2012 | 355 | 2012 |
| Targeting the NFκB signaling pathways for breast cancer prevention and therapy W Wang, SA Nag, R Zhang Current medicinal chemistry 22 (2), 264-289, 2015 | 237 | 2015 |
| Ribosomal proteins and human diseases: pathogenesis, molecular mechanisms, and therapeutic implications W Wang, S Nag, X Zhang, MH Wang, H Wang, J Zhou, R Zhang Medicinal research reviews 35 (2), 225-285, 2015 | 213 | 2015 |
| NFAT as cancer target: mission possible? JJ Qin, S Nag, W Wang, J Zhou, WD Zhang, H Wang, R Zhang Biochimica Et Biophysica Acta (BBA)-Reviews on Cancer 1846 (2), 297-311, 2014 | 153 | 2014 |
| Targeting MDM2-p53 interaction for cancer therapy: are we there yet? S Nag, X Zhang, KS Srivenugopal, MH Wang, W Wang, R Zhang Current medicinal chemistry 21 (5), 553-574, 2014 | 142 | 2014 |
| Polycomb group (PcG) proteins and human cancers: multifaceted functions and therapeutic implications W Wang, JJ Qin, S Voruganti, S Nag, J Zhou, R Zhang Medicinal research reviews 35 (6), 1220-1267, 2015 | 132 | 2015 |
| Natural Product Ginsenoside 25-OCH3-PPD Inhibits Breast Cancer Growth and Metastasis through Down-Regulating MDM2 W Wang, X Zhang, JJ Qin, S Voruganti, SA Nag, MH Wang, H Wang, ... PLoS One 7 (7), e41586, 2012 | 96 | 2012 |
| The pyrido[b]indole MDM2 inhibitor SP-141 exerts potent therapeutic effects in breast cancer models W Wang, JJ Qin, S Voruganti, KS Srivenugopal, S Nag, S Patil, H Sharma, ... Nature communications 5 (1), 5086, 2014 | 93 | 2014 |
| Ginsenoside Rh1: a systematic review of its pharmacological properties DNH Tam, DH Truong, TTH Nguyen, L Tran, HD Nguyen, ... Planta Medica 84 (03), 139-152, 2018 | 83 | 2018 |
| Oral nano-delivery of anticancer ginsenoside 25-OCH3-PPD, a natural inhibitor of the MDM2 oncogene: Nanoparticle preparation, characterization, in vitro and in vivo anti … S Voruganti, JJ Qin, S Sarkar, S Nag, IA Walbi, S Wang, Y Zhao, W Wang, ... Oncotarget 6 (25), 21379, 2015 | 66 | 2015 |
| Natural product MDM2 inhibitors: anticancer activity and mechanisms of action JJ Qin, S Nag, S Voruganti, W Wang, R Zhang Current medicinal chemistry 19 (33), 5705-5725, 2012 | 65 | 2012 |
| RYBP expression is associated with better survival of patients with hepatocellular carcinoma (HCC) and responsiveness to chemotherapy of HCC cells in vitro and in vivo W Wang, J Cheng, JJ Qin, S Voruganti, S Nag, J Fan, Q Gao, R Zhang Oncotarget 5 (22), 11604, 2014 | 56 | 2014 |
| Selective cytotoxicity, inhibition of cell cycle progression, and induction of apoptosis in human breast cancer cells by sesquiterpenoids from Inula lineariifolia Turcz. JJ Qin, HZ Jin, Y Huang, SD Zhang, L Shan, S Voruganti, S Nag, W Wang, ... European journal of medicinal chemistry 68, 473-481, 2013 | 45 | 2013 |
| miRNAs in cancer prevention and treatment and as molecular targets for natural product anticancer agents B Qian, SA Nag, Y Su, S Voruganti, JJ Qin, R Zhang, W Cho Current cancer drug targets 13 (5), 519-541, 2013 | 35 | 2013 |
| KCN1, a Novel Synthetic Sulfonamide Anticancer Agent: In Vitro and In Vivo Anti-Pancreatic Cancer Activities and Preclinical Pharmacology W Wang, L Ao, ER Rayburn, H Xu, X Zhang, X Zhang, SA Nag, X Wu, ... Public Library of Science 7 (9), e44883, 2012 | 33 | 2012 |
| In vitro metabolism of benzo[a]pyrene-7,8-dihydrodiol and dibenzo[def,p]chrysene-11,12 diol in rodent and human hepatic microsomes RAC Smith JN, D Mehinagic, S Nag, SR Crowell Toxicology Letters 269, 23-32, 2017 | 20 | 2017 |
| Benzo[a]pyrene Induction of Glutathione S-Transferases: An Activity-Based Protein Profiling Investigation EG Stoddard, BJ Killinger, SA Nag, J Martin, R Corley, JN Smith, ... Chemical research in toxicology 32 (6), 1259-1267, 2019 | 17 | 2019 |
| Development and validation of a rapid HPLC method for quantitation of SP‐141, a novel pyrido [b] indole anticancer agent, and an initial pharmacokinetic study in mice S Nag, JJ Qin, S Voruganti, MH Wang, H Sharma, S Patil, JK Buolamwini, ... Biomedical Chromatography 29 (5), 654-663, 2015 | 14 | 2015 |
| Exposure to an environmental mixture of polycyclic aromatic hydrocarbons induces hepatic cytochrome P450 enzymes in mice EG Stoddard, S Nag, J Martin, KJ Tyrrell, T Gibbins, KA Anderson, ... Chemical research in toxicology 34 (9), 2145-2156, 2021 | 13 | 2021 |
